Antimicrobial peptide LL-37 on surfaces presenting carboxylate anions

被引:18
|
作者
Qin, G. T. [1 ,2 ]
Lopez, A. [1 ]
Santos, C. [1 ]
McDermott, A. M. [2 ]
Cai, C. Z. [1 ]
机构
[1] Univ Houston, Dept Chem, Houston, TX 77204 USA
[2] Univ Houston, Coll Optometry, Ocular Surface Inst, Houston, TX 77204 USA
基金
美国国家科学基金会;
关键词
NEUTROPHIL EXTRACELLULAR TRAPS; ANTIBACTERIAL PEPTIDE; SILVER NANOPARTICLES; CATHELICIDIN LL-37; F-ACTIN; IMMOBILIZATION; DNA; POLYMERIZATION; ATTACHMENT; RESISTANCE;
D O I
10.1039/c5bm00055f
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Antimicrobial peptides (AMPs) are part of the immune system in a wide range of organisms. They generally carry positive charges under physiological conditions, allowing them to accumulate on the negatively charged bacterial membrane as the first step of bactericidal action. The concentration range of AMPs necessary for rapid killing of bacteria tested in vitro is much higher than levels found at epithelial surfaces and body fluids in vivo, and close to the a level that is toxic to the host cells. It is likely that AMPs in vivo are localized and act cooperatively to enhance antimicrobial activity, while the global concentration is low thus demonstrating low toxicity to host cells. Herein we employed well-defined mixed self-assembled monolayers (SAMs) to localize LL-37, one of the most studied AMPs, via electrostatic interactions. We systematically varied the surface density of LL-37, and found that the immobilized AMPs not only attracted bacteria Pseudomonas aeruginosa to the surface, but also killed nearly all bacteria when above a threshold density. More significantly, the AMPs displayed low toxicity to human corneal epithelial cells. The results indicated that localization of AMPs on suitable polyanion substrates facilitated the bactericidal activity while minimizing the cytotoxicity of AMPs.
引用
收藏
页码:771 / 778
页数:8
相关论文
共 50 条
  • [1] Human antimicrobial peptide LL-37
    Yang, YH
    Ma, WR
    Zheng, GG
    Wu, KF
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2003, 30 (06) : 847 - 851
  • [2] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [3] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Robert Bucki
    Katarzyna Leszczyńska
    Andrzej Namiot
    Wojciech Sokołowski
    Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 : 15 - 25
  • [4] Antimicrobial peptide LL-37 in human atherosclerosis
    Edfeldt, K.
    Agerberth, B.
    Rottenberg, M. E.
    Gudmundsson, G. H.
    Mandal, K.
    Xu, Q. B.
    Hansson, G. K.
    Yan, Z. Q.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 407 - 407
  • [5] Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides
    Martynowycz, Michael
    Rice, Amy
    Andreev, Konstantin
    Pavinatto, Thatyane M. Nobre
    Wereszczynski, Jeff
    Gidalevitz, David
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 45A - 45A
  • [6] Salivary concentration of the antimicrobial peptide LL-37 in children
    Davidopoulou, Sotiria
    Diza, Eudoxia
    Menexes, Georgios
    Kalfas, Sotirios
    ARCHIVES OF ORAL BIOLOGY, 2012, 57 (07) : 865 - 869
  • [7] Involvement of the antimicrobial peptide LL-37 in human atherosclerosis
    Edfeldt, Kristina
    Agerberth, Birgitta
    Rottenberg, Martin E.
    Gudmundsson, Gudmundur H.
    Wang, Xiong-Biao
    Mandal, Kaushik
    Xu, Qingbo
    Yan, Zhong-qun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) : 1551 - 1557
  • [8] The Antimicrobial Peptide, LL-37, Inhibits in vitro Osteoclastogenesis
    Supanchart, C.
    Thawanaphong, S.
    Makeudom, A.
    Bolscher, J. G.
    Nazmi, K.
    Kornak, U.
    Krisanaprakornkit, S.
    JOURNAL OF DENTAL RESEARCH, 2012, 91 (11) : 1071 - 1077
  • [9] Inactivation of the antimicrobial peptide LL-37 by pathogenic Leptospira
    Oliveira, Priscila N.
    Courrol, Daniella S.
    Chura-Chambi, Rosa Maria
    Morganti, Ligia
    Souza, Gisele O.
    Franzolin, Marcia R.
    Wunder Jr, Elsio A.
    Heinemann, Marcos B.
    Barbosa, Angela S.
    MICROBIAL PATHOGENESIS, 2021, 150
  • [10] Cubosomes for topical delivery of the antimicrobial peptide LL-37
    Boge, Lukas
    Hallstensson, Karin
    Ringstad, Lovisa
    Johansson, Jenny
    Andersson, Therese
    Davoudi, Mina
    Larsson, Per Tomas
    Mahlapuu, Margit
    Hakansson, Joakim
    Andersson, Martin
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2019, 134 : 60 - 67